Research reveals that survival disparities by insurance coverage have widened after immune checkpoint inhibitors approval for stage IV cancers, urging policy action to improve access and affordability.

Former President Joe Biden diagnosed with aggressive prostate cancer that has spread to bones. Hormone-sensitive, high Gleason score cancer poses treatment challenges but remains manageable with hormone therapy. Biden's diagnosis brings attention to advanced prostate cancer treatment and related health policy discussions.